Health Condition 1: D496- Neoplasm of unspecified behavior of brain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients of either gender 2)Age 18 to 65 years 3)ASA class I and II 4)Patients with GCS 12 to 15
Exclusion criteria
Exclusion criteria: 1)Patient refusal 2)Patients with anticipated difficult airway 3)Patients with hypertension or respiratory disorders or hepatic dysfunction or renal dysfunction 4)Patients undergoing emergency surgery 5)Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the hemodynamic response between the intranasal, nebulized, and intravenous dexmedetomidine as premedication for blunting laryngoscopy and tracheal intubation response.Timepoint: Till 15 minutes after intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the sedation score To compare the adverse effects of dexmedetomidine administration via three routesTimepoint: Till 15 minutes after intubation | — |
Countries
India
Contacts
AIMS, RAIPUR